Pfizer (NYSE:PFE) has been dismissed as a defendant in a major federal lawsuit alleging generic drug price fixing. The court ...

When life sciences startups think about patent strategy, the natural instinct is to focus on the core science — the novel compound, the ...

Indian companies filed 184 Type II DMFs with the US FDA in Q1 2026 against China's 149, reinforcing the country's leadership ...

The National Healthcare Security Administration said on Monday that 557 drugs have passed the preliminary review for ...

On June 16, 2025, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule, “Medicare Drug Price Negotiation Program and ...

With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market ...

While multinational pharmaceutical companies use India to test out their new medicines, India’s researchers rarely lead the ...

Demand for GLP-1 drugs such as semaglutide is exposing capacity gaps across peptide APIs, sterile fill-finish facilities, ...

Universities and hospitals are repurposing existing drugs through late-stage trials with funded costs up to 90% lower than those taking place in the ...

FDA takes an industry-friendly approach; Trump aide in consideration to lead FDA; Biotech CEOs are suddenly bullish.

As drug costs and spending continue to rise, the demand for solutions opens the door to closer collaboration between payers ...

As radiopharmaceutical therapy (RPT) expands beyond neuroendocrine tumors and prostate cancer, it is important to understand ...